Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
ACS Appl Mater Interfaces ; 13(2): 3237-3245, 2021 Jan 20.
Article de Anglais | MEDLINE | ID: mdl-33405504

RÉSUMÉ

Cationic polymers are promising antibacterial agents because bacteria have a low propensity to develop resistance against them, but they usually have low biocompatibility because of their hydrophobic moieties. Herein, we report a new biodegradable and biocompatible chitosan-derived cationic antibacterial polymer, 2,6-diamino chitosan (2,6-DAC). 2,6-DAC shows excellent broad-spectrum antimicrobial activity with minimum inhibitory concentrations (MICs) of 8-32 µg/mL against clinically relevant and multidrug-resistant (MDR) bacteria including Listeria monocytogenes, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Furthermore, 2,6-DAC shows an excellent synergistic effect with various clinically relevant antibiotics proved by decreasing the MICs of the antibiotics against MDR A. baumannii and methicillin-resistant Staphylococcus aureus to <1 µg/mL. In vivo biocompatibility of 2,6-DAC is proved by a dosage of 100 mg/kg compound via oral administration and 25 mg/kg compound via intraperitoneal injection to mice; 2,6-DAC does not cause any weight loss and any significant change in liver and kidney biomarkers or the important blood electrolytes. The combinations of 2,6-DAC together with novobiocin and rifampicin show >2.4 log10 reduction of A. baumannii in murine intraperitoneal and lung infection models. The novel chitosan derivative, 2,6-DAC, can be utilized as a biocompatible broad-spectrum cationic antimicrobial agent alone or in synergistic combination with various antibiotics.


Sujet(s)
Antibactériens/composition chimique , Antibactériens/pharmacologie , Bactéries/effets des médicaments et des substances chimiques , Chitosane/analogues et dérivés , Chitosane/pharmacologie , Animaux , Infections bactériennes/traitement médicamenteux , Synergie des médicaments , Femelle , Humains , Staphylococcus aureus résistant à la méticilline/effets des médicaments et des substances chimiques , Souris de lignée BALB C , Tests de sensibilité microbienne
2.
Macromol Rapid Commun ; 41(21): e2000175, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-32803821

RÉSUMÉ

Contact lenses are medical devices commonly used to correct refractive errors and to maintain ocular health. Microorganisms such as bacteria that grow on the lens surface cause irritation to the eyes and can even cause loss of vision. In this paper, two different coating strategies are employed to form an efficient antimicrobial coating on contact lenses. In the first method, a presynthesized copolymer of polyethyleneimine-graft-polyethylene glycol methacrylate (PEI-PEGMA) is used and the coated lenses show antimicrobial activity (in vitro) against methicillin-resistant Staphylococcus aureus (MRSA) bacteria with killing efficacy >99.99% and log reduction of 5.1 and proxy host cell viability of 79%. In the second method, commercially available monomers/polymers such as glycidyl methacrylate (GMA), sulfobetaine methacrylate, and polyethyleneimine are used. A typical formulation consisting of 1% GMA shows antibacterial activity against MRSA with killing efficacy >99.99% and log reduction of 6.3. Proxy host cell viability for the coated lenses is found to be 90% indicating that the coating is nontoxic. Antibacterial coating reported here is very effective in killing gram-positive bacteria such as MRSA and S. aureus. The second method using commercially available monomers/polymers involving a simple coating procedure is also easily scalable.


Sujet(s)
Anti-infectieux , Lentilles de contact , Staphylococcus aureus résistant à la méticilline , Antibactériens/pharmacologie , Anti-infectieux/pharmacologie , Matériaux revêtus, biocompatibles , Composés époxy , Méthacrylates , Polyéthylèneimine , Polymères , Silicone , Staphylococcus aureus
3.
ACS Infect Dis ; 6(5): 1228-1237, 2020 05 08.
Article de Anglais | MEDLINE | ID: mdl-32138506

RÉSUMÉ

Antibiotic-resistant infections are predicted to kill 10 million people worldwide per year by 2050 and to cost the global economy 100 trillion USD. Novel approaches and alternatives to conventional antibiotics are urgently required to combat antimicrobial resistance. We have synthesized a chitosan-based oligolysine antimicrobial peptide, CSM5-K5 (where CSM denotes chitosan monomer repeat units and K denotes lysine amino acid repeat units), that targets multidrug-resistant (MDR) bacterial species. Here, we show that CSM5-K5 exhibits rapid bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA), MDR Escherichia coli, and vancomycin-resistant Enterococcus faecalis (VRE). Combinatorial therapy of CSM5-K5 with antibiotics to which each organism is otherwise resistant restores sensitivity to the conventional antibiotic. CSM5-K5 alone significantly reduced preformed bacterial biofilm by 2-4 orders of magnitude and, in combination with conventional antibiotics, reduced preformed biofilm by more than 2-3 orders of magnitude at subinhibitory concentrations. Moreover, using a mouse excisional wound infection model, CSM5-K5 treatment reduced bacterial burdens by 1-3 orders of magnitude and acted synergistically with oxacillin, vancomycin, and streptomycin to clear MRSA, VRE, and MDR E. coli, respectively. Importantly, little to no resistance against CSM5-K5 arose for any of the three MDR bacteria during 15 days of serial passage. Furthermore, low level resistance to CSM5-K5 that did arise for MRSA conferred increased susceptibility (collateral sensitivity) to the ß-lactam antibiotic oxacillin. This work demonstrates the feasibility and benefits of using this synthetic cationic peptide as an alternative to, or in combination with, traditional antibiotics to treat infections caused by MDR bacteria.


Sujet(s)
Antibactériens , Peptides antimicrobiens cationiques/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Staphylococcus aureus résistant à la méticilline/effets des médicaments et des substances chimiques , Entérocoques résistants à la vancomycine/effets des médicaments et des substances chimiques , Antibactériens/pharmacologie , Enterococcus faecalis/effets des médicaments et des substances chimiques , Polymères
4.
ACS Appl Mater Interfaces ; 10(24): 20356-20367, 2018 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-29806938

RÉSUMÉ

Multidrug resistance and the refractory character of bacterial biofilms are among the most difficult challenges in infection treatment. Current antimicrobial strategies typically are much more effective for prevention of biofilm formation than for eradication of established biofilms; these strategies also leave dead bacteria and endotoxin in the infection site, which impairs healing. We report a novel hydrogel that eradicates biofilm bacteria by non-leaching-based debridement followed by ex situ contact-killing (DESCK) away from the infection site. The debridement effect is likely due to the high water swellability and microporosity of the cross-linked network which is made from polyethylene glycol dimethacrylate tethered with a dangling polyethylenimine (PEI) star copolymer. The large pore size of the hydrogel makes the cationic pore walls highly accessible to bacteria. The hydrogel also degrades in the presence of infection cells, releasing star cationic PEI into the infection site to contact-kill bacteria remaining there. DESCK hydrogel effectively kills (>99.9% reduction) biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Pseudomonas aeruginosa (CR-PA) and Acinetobacter baumannii in a murine excisional wound infection model. Silver-based wound dressings (controls) showed almost no killing of CR-PA and MRSA biofilms. This DESCK hydrogel greatly reduces the bioburden and inflammation and promotes wound healing. It has great potential for diverse infection treatment applications.


Sujet(s)
Biofilms , Animaux , Antibactériens , Débridement , Résistance bactérienne aux médicaments , Multirésistance aux médicaments , Hydrogels , Staphylococcus aureus résistant à la méticilline , Souris , Pseudomonas aeruginosa , Infection de plaie
5.
ACS Nano ; 9(10): 10142-57, 2015 Oct 27.
Article de Anglais | MEDLINE | ID: mdl-26389519

RÉSUMÉ

Water disinfection materials should ideally be broad-spectrum-active, nonleachable, and noncontaminating to the liquid needing sterilization. Herein, we demonstrate a high-performance capacitive deionization disinfection (CDID) electrode made by coating an activated carbon (AC) electrode with cationic nanohybrids of graphene oxide-graft-quaternized chitosan (GO-QC). Our GO-QC/AC CDID electrode can achieve at least 99.9999% killing (i.e., 6 log reduction) of Escherichia coli in water flowing continuously through the CDID cell. Without the GO-QC coating, the AC electrode alone cannot kill the bacteria and adsorbs a much smaller fraction (<82.8 ± 1.8%) of E. coli from the same biocontaminated water. Our CDID process consists of alternating cycles of water disinfection followed by electrode regeneration, each a few minutes duration, so that this water disinfection process can be continuous and it only needs a small electrode voltage (2 V). With a typical brackish water biocontamination (with 10(4) CFU mL(-1) bacteria), the GO-QC/AC electrodes can kill 99.99% of the E. coli in water for 5 h. The disinfecting GO-QC is securely attached on the AC electrode surface, so that it is noncontaminating to water, unlike many other chemicals used today. The GO-QC nanohybrids have excellent intrinsic antimicrobial properties in suspension form. Further, the GO component contributes toward the needed surface conductivity of the CDID electrode. This CDID process offers an economical method toward ultrafast, contaminant-free, and continuous killing of bacteria in biocontaminated water. The proposed strategy introduces a green in situ disinfectant approach for water purification.


Sujet(s)
Chitosane/composition chimique , Désinfection/instrumentation , Escherichia coli/isolement et purification , Graphite/composition chimique , Nanostructures/composition chimique , Microbiologie de l'eau , Purification de l'eau/instrumentation , Désinfection/économie , Conductivité électrique , Électrodes , Conception d'appareillage , Nanostructures/ultrastructure , Oxydes/composition chimique , Purification de l'eau/économie
6.
J Org Chem ; 74(15): 5174-80, 2009 Aug 07.
Article de Anglais | MEDLINE | ID: mdl-19719250

RÉSUMÉ

The intermolecular oxypalladation of chiral nonracemic allylic alcohols (S)-1, (R)-1, and (R)-3 in methanol gave chiral nonracemic methyl allyl ethers (S)-2 and/or (R)-2 with excellent selectivity. The reaction induced the 1,3-chirality transfer to give syn-S(N)2' product exclusively through syn oxypalladation. On the other hand, the anti-S(N)2' product was produced in 20-33% in THF, toluene, and CH2Cl2 and predominantly in CH3CN. The pi-olefin-Pd complexes I and II are proposed as important intermediates to explain the syn- and anti-oxypalladation pathways. The byproduct 9 was formed through the second syn-oxypalladation from the methyl allyl ether 2, though the rate of this second reaction was far slower than that of allylic alcohol.


Sujet(s)
Éthers/composition chimique , Méthanol/composition chimique , Composés organométalliques/composition chimique , Palladium/composition chimique , Propanols/composition chimique , Catalyse , Éthers/synthèse chimique , Structure moléculaire , Stéréoisomérie
7.
Chem Asian J ; 3(2): 473-84, 2008 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-18203216

RÉSUMÉ

Pd(II)-catalyzed cyclizations of chiral epsilon-, zeta-, and eta-hydroxy-alpha,beta-unsaturated alcohols are described. The reactions took place stereospecifically to give chiral 2,5-disubstituted tetrahydrofurans, 2,6-disubstituted tetrahydropyrans, and 2,7-disubstituted oxepanes, respectively. The chirality of the carbon center of the chiral allylic alcohol is transferred stereospecifically to the carbon center of the newly generated oxacyclic ring. A plausible reaction mechanism involves 1) chiral-allylic-alcohol-induced syn facioselective formation of a Pd pi-complex, 2) syn oxypalladation, and 3) syn elimination of PdCl(OH), which provide a rational account for the stereochemical results.


Sujet(s)
Oxygène/composition chimique , Palladium/composition chimique , Alcools/composition chimique , Catalyse , Cyclisation , Structure moléculaire , Stéréoisomérie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...